Merck Stops Developing Both Of Its COVID-19 Vaccine Candidates

Content Curator
Pharmaceutical company Merck says is shelving its two COVID-19 vaccine candidates, saying that the results of clinical trials fell short of its goals.

Merck, which previously made an Ebola vaccine, had been seen as a serious contender in the worldwide race to come up with an answer to COVID-19.

(Image credit: Budrul Chukrut/SOPA Images/LightRocket via Getty Images)